# Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers

> **NCT03323424** · PHASE2 · WITHDRAWN · sponsor: **Institut de Cancérologie de la Loire**

## Conditions studied

- Metastatic Breast Cancer
- Metastatic Colorectal Cancer
- Metastatic Head and Neck Cancer

## Interventions

- **RADIATION:** Systemic treatment + Stereotactic Body Radio-Therapy (SBRT)
- **OTHER:** Systemic treatment

## Key facts

- **NCT ID:** NCT03323424
- **Lead sponsor:** Institut de Cancérologie de la Loire
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-01
- **Primary completion:** 2021-02-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patient enrolled during the authorized period
- **Last updated:** 2020-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03323424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03323424, "Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03323424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*